Literature DB >> 6796903

Inhibitory effects of sodium valproate on oxidative phosphorylation.

R Haas, D A Stumpf, J K Parks, L Eguren.   

Abstract

Sodium valproate (VP) inhibited oxidative phosphorylation in isolated rat liver mitochondria. State 3 rates of oxygen consumption with glutamate as substrate were 80% of control values at a low VP concentration (24 microM). At 240 microM, there was more than 50% inhibition of glutamate and alpha-ketoglutarate state 3 rates. Succinate state 3 rates were 80% of control values, and uncoupling was noted at 2400 microM VP. These VP effects were similar to those of propionate and isovalerate, suggesting a common mechanism of toxicity. Inhibition of mitochondrial oxidative phosphorylation may explain why VP intoxication causes a hepatocerebral disorder that resembles Reye syndrome.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6796903     DOI: 10.1212/wnl.31.11.1473

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  15 in total

1.  Valproate inhibits the mitochondrial pyruvate-driven oxidative phosphorylation in vitro.

Authors:  M F Silva; J P Ruiter; L Illst; C Jakobs; M Duran; I T de Almeida; R J Wanders
Journal:  J Inherit Metab Dis       Date:  1997-07       Impact factor: 4.982

2.  Psychotropic medications and mitochondrial toxicity.

Authors:  Rebecca Anglin; Patricia Rosebush; Michael Mazurek
Journal:  Nat Rev Neurosci       Date:  2012-07-25       Impact factor: 34.870

Review 3.  Biochemical relationships between Reye's and Reye's-like metabolic and toxicological syndromes.

Authors:  J Osterloh; W Cunningham; A Dixon; D Combest
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Jul-Aug

Review 4.  Neurodevelopmental manifestations of mitochondrial disease.

Authors:  Marni J Falk
Journal:  J Dev Behav Pediatr       Date:  2010-09       Impact factor: 2.225

5.  Inactivation of beef brain alpha-ketoglutarate dehydrogenase complex by valproic acid and valproic acid metabolites. Possible mechanism of anticonvulsant and toxic actions.

Authors:  A S Luder; J K Parks; F Frerman; W D Parker
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

Review 6.  Treatment of mitochondrial disease.

Authors:  R W Taylor; P F Chinnery; K M Clark; R N Lightowlers; D M Turnbull
Journal:  J Bioenerg Biomembr       Date:  1997-04       Impact factor: 2.945

Review 7.  Biochemical diagnosis of mitochondrial disorders.

Authors:  Richard J T Rodenburg
Journal:  J Inherit Metab Dis       Date:  2010-05-04       Impact factor: 4.982

Review 8.  Carnitine transport: pathophysiology and metabolism of known molecular defects.

Authors:  I Tein
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

Review 9.  Valproate-associated hepatotoxicity and its biochemical mechanisms.

Authors:  M J Eadie; W D Hooper; R G Dickinson
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Mar-Apr

10.  Single valproic acid treatment inhibits glycogen and RNA ribose turnover while disrupting glucose-derived cholesterol synthesis in liver as revealed by the [U-C(6)]-d-glucose tracer in mice.

Authors:  Richard D Beger; Deborah K Hansen; Laura K Schnackenberg; Brandie M Cross; Javad J Fatollahi; F Tracy Lagunero; Zoltan Sarnyai; Laszlo G Boros
Journal:  Metabolomics       Date:  2009-03-31       Impact factor: 4.290

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.